Severe pulmonary toxoplasmosis after allo-SCT in two patients: From Toxoplasma genotyping to clinical management

Bone Marrow Transplantation

Volumn 45, Issue 3, 2010, Pages 580-583

  Delhaes, L ^a   Mraz, J C ^a   Frealle E ^a   Durand Joly, I ^a   Magro, L ^a   Ajzenberg, D ^b,c   Darde M L ^b,c   Dei Cas, E ^a   Yakoub Agha, I ^a  

^a UNIV LILLE   (France)

^b LIMOGES UNIVERSITY HOSPITAL   (France)

^c UNIVERSITY OF LIMOGES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ATOVAQUONE; BUSULFAN; CEFTAZIDIME; CLINDAMYCIN; CORTICOSTEROID; COTRIMOXAZOLE; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; DOXORUBICIN; FLUDARABINE; FOSCARNET; GANCICLOVIR; INTERLEUKIN 2 RECEPTOR ANTIBODY; METHYLPREDNISOLONE; METRONIDAZOLE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PYRIMETHAMINE; ROXITHROMYCIN; STEROID; THYMOCYTE ANTIBODY; VANCOMYCIN; VINCRISTINE;

ACUTE RESPIRATORY FAILURE; ADOLESCENT; ADULT; ALLOGENEIC STEM CELL TRANSPLANTATION; AUTOPSY; CASE REPORT; CHRONIC LYMPHATIC LEUKEMIA; COMPUTER ASSISTED TOMOGRAPHY; CONFUSION; CYTOMEGALOVIRUS INFECTION; DEATH; DRUG WITHDRAWAL; ENGRAFTMENT; FEMALE; FEVER; FIBROBLAST CULTURE; GENOTYPE; GRAFT VERSUS HOST REACTION; HEMOLYTIC UREMIC SYNDROME; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOXEMIA; INTERSTITIAL LUNG DISEASE; LETTER; LIVER TOXICITY; LUNG INFILTRATE; LUNG LAVAGE; MALE; MYELOABLATIVE CONDITIONING; NEPHROTOXICITY; NEUTROPENIA; PRIORITY JOURNAL; REDUCED INTENSITY CONDITIONING; REFRACTORY ANEMIA WITH EXCESS BLASTS; SERODIAGNOSIS; TOXOPLASMA GONDII; TOXOPLASMOSIS; WHOLE BODY RADIATION;

ADOLESCENT; ADULT; ANTIPROTOZOAL AGENTS; CORD BLOOD STEM CELL TRANSPLANTATION; FEMALE; GENOTYPE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMMUNOCOMPROMISED HOST; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; LUNG DISEASES, PARASITIC; MALE; MYELODYSPLASTIC SYNDROMES; OPPORTUNISTIC INFECTIONS; RISK FACTORS; TOXOPLASMA; TOXOPLASMOSIS; TRANSPLANTATION, HOMOLOGOUS;

EID: 77949424371     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/bmt.2009.167     Document Type: Letter

References (10)

1. Derouin F, Pelloux H, ESCMID Study Group on Clinical Parasitology. Prevention of toxoplasmosis in transplant patients. Clin Microbiol Infect 2008; 14: 1089-1101.
2. Ajzenberg D, Yera H, Marty P, Paris L, Dalle F, Menotti J et al. Genotype of 88 Toxoplasma gondii isolates associated with toxoplasmosis in immunocompromised patients, and correlation with clinical findings. J Infect Dis 2009; 199: 1155-1167.
3. Goebel WS, Conway JH, Faught P, Vakili ST, Haut PR. Disseminated toxoplasmosis resulting in graft failure in a cord blood stem cell transplant recipient. Pediatr Blood Cancer 2007; 48: 222-226.
4. Longoni DV, Fumagalli R, Fumagalli M, Cappellini A, Uderzo C. Severe disseminated toxoplasmosis after unrelated bone marrow transplantation: a case report. Haematologica 2000; 85: 781-782.
5. Chandrasekar PH, Momin F. Disseminated toxoplasmosis in marrow recipients: a report of three cases and a review of the literature. Bone Marrow Transplant Team. Bone Marrow Transplant 1997; 19: 685-689.
6. Vaessen N, Verweij JJ, Spijkerman IJ, van Hoek B, van Lieshout L. Fatal disseminated toxoplasmosis after liver transplantation: improved and early diagnosis by PCR. Neth J Med 2007; 65: 222-223.
7. Foot AB, Garin YJ, Ribaud P, Devergie A, Derouin F, Gluckman E. Prophylaxis of toxoplasmosis infection with pyrimethamine/sulfadoxine (Fansidar) in bone marrow transplant recipients. Bone Marrow Transplant 1994; 14: 241-245.
8. Carme B, Bissuel F, Ajzenberg D, Bouyne R, Aznar C, Demar M et al. Severe acquired toxoplasmosis in immunocompetent adult patients in French Guiana. J Clin Microbiol 2002; 40: 4037-4044.
9. Khan A, Fux B, Su C, Dubey JP, Darde ML, Ajioka JW et al. Recent transcontinental sweep of Toxoplasma gondii driven by a single monomorphic chromosome. Proc Natl Acad Sci USA 2007; 104: 14872-14877.
10. Sousa S, Ajzenberg D, Vilanova M, Costa J, Dardé ML. Use of GRA6-derived synthetic polymorphic peptides in an immunoenzymatic assay to serotype Toxoplasma gondii in human serum samples collected from three continents. Clin Vaccine Immunol 2008; 15: 1380-1386.